Diminished levels of the soluble form of RAGE are related to poor survival in malignant melanoma

Ultraviolet-radiation-induced inflammation promotes angiotropism and metastasis in melanoma

(2014) Tobias Bald et al.   NATURE

RAGE regulation and signaling in inflammation and beyond

(2013) Katrin Kierdorf et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Cutaneous melanoma

(2013) Alexander MM Eggermont et al.   LANCET

Common Interactions between S100A4 and S100A9 Defined by a Novel Chemical Probe

(2013) Per Björk et al.   PLoS One

Neutralizing Tumor-Promoting Chronic Inflammation: A Magic Bullet?

(2013) L. M. Coussens et al.   SCIENCE

Serum markers lactate dehydrogenase and S100B predict independently disease outcome in melanoma patients with distant metastasis

(2012) B Weide et al.   BRITISH JOURNAL OF CANCER

The Associations of Advanced Glycation End Products and Its Soluble Receptor with Pancreatic Cancer Risk: A Case-Control Study within the Prospective EPIC Cohort

(2012) V. A. Grote et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Functions of S100 Proteins

(2012) R. Donato et al.   CURRENT MOLECULAR MEDICINE

RAGE Genetic Polymorphisms Are Associated with Risk, Chemotherapy Response and Prognosis in Patients with Advanced NSCLC

(2012) Xiang Wang et al.   PLoS One

pROC: an open-source package for R and S+ to analyze and compare ROC curves

(2011) Xavier Robin et al.   BMC BIOINFORMATICS

The G82S Polymorphism Promotes Glycosylation of the Receptor for Advanced Glycation End Products (RAGE) at Asparagine 81

(2011) Sun Jin Park et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

RAGE Gene Deletion Inhibits the Development and Progression of Ductal Neoplasia and Prolongs Survival in a Murine Model of Pancreatic Cancer

(2011) Joseph DiNorcia et al.   JOURNAL OF GASTROINTESTINAL SURGERY

HMGB1 and RAGE in Inflammation and Cancer

(2010) Gary P. Sims et al.   Annual Review of Immunology

Insulin-like growth factor II mRNA binding protein 3 (IMP3) is overexpressed in prostate cancer and correlates with higher Gleason scores

(2010) Kristian Ikenberg et al.   BMC CANCER

Soluble receptor for advanced glycation end-products (sRAGE) and polymorphisms of RAGE and glyoxalase I genes in patients with pancreas cancer

(2010) Tomáš Krechler et al.   CLINICAL BIOCHEMISTRY

Somatic alterations in the melanoma genome: A high-resolution array-based comparative genomic hybridization study

(2010) Andreas Gast et al.   GENES CHROMOSOMES & CANCER

Lack of an Endogenous Anti-inflammatory Protein in Mice Enhances Colonization of B16F10 Melanoma Cells in the Lungs

(2010) Arjun Saha et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Receptor for advanced glycation end products (RAGE) soluble form (sRAGE): a new biomarker for lung cance

(2010) R. JING et al.   NEOPLASMA

Final Version of 2009 AJCC Melanoma Staging and Classification

(2009) Charles M. Balch et al.   JOURNAL OF CLINICAL ONCOLOGY

Association between the RAGE G82S polymorphism and Alzheimer’s disease

(2009) Keshen Li et al.   JOURNAL OF NEURAL TRANSMISSION

Expression of Receptor for Advanced Glycation End Products (RAGE) is Related to Prognosis in Patients with Esophageal Squamous Cell Carcinoma

(2008) Taro Tateno et al.   ANNALS OF SURGICAL ONCOLOGY

RAGE, carboxylated glycans and S100A8/A9 play essential roles in colitis-associated carcinogenesis

(2008) Olga Turovskaya et al.   CARCINOGENESIS

Gly82Ser Polymorphism of the Receptor for Advanced Glycation End Products Is Associated with an Increased Risk of Gastric Cancer in a Chinese Population

(2008) H. Gu et al.   CLINICAL CANCER RESEARCH

A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10)

(2008) Angela Raucci et al.   FASEB JOURNAL

RAGE signaling sustains inflammation and promotes tumor development

(2008) Christoffer Gebhardt et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Melanoma and the tumor microenvironment

(2008) Jessie Villanueva et al.   Current Oncology Reports

Identification, classification, and expression of RAGE gene splice variants

(2007) Barry I. Hudson et al.   FASEB JOURNAL